BlueOcean Ventures
BlueOcean Ventures SA provides capital, operational, and company development advisory support to their customers.
Business Model:
Revenue: $3M
Employees: 2-10
Rankings
Industries / Tags:
Detailed BlueOcean Ventures Information
Geographic Data
Address: 3 Chemin du Pré-Fleuri
City: Geneva
State: geneva
Zip: 1228
Country: CH
Financial Info
Stage:
Raised Last:
$0
Raised Total:$26M
Social
Linkedin
Crunchbase
Metrics
8,981,890Website Global Rank
342Website Monthly Traffic
Twitter Followers
Description
BlueOcean Ventures SA provides capital, operational and company development advisory support (mentoring, company management, divestment experience, network, negotiation support) to entrepreneurs in Switzerland. BlueOcean Ventures is based in Geneva, Switzerland.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 2/2011 | official.fm | Venture Round | 5M |
| 6/2020 | Mikajaki | Seed Round | 2.5M |
| 2/2010 | Viroblock | Series B | - |
| 12/2007 | SENSIMED | Series A | 6.9M |
| 4/2020 | CyanoGuard AG | Seed Round | 3.1M |
| 11/2016 | Ava | Series A | 0 |
| 8/2013 | Distalmotion | Series A | - |
| 10/2016 | Rheon Medical | Venture Round | - |
| 6/2017 | 99RetailStreet | Seed Round | - |
| 10/2014 | Abionic | Series B | 0 |
| 4/2012 | Abionic | Series A | 0 |
| 3/2011 | Anergis | Series A | 20M |
| 7/2011 | Myopowers Medical Technologies | Series B | 16M |
| 1/2014 | Augurix | Venture Round | 3.3M |
| 6/2020 | Mikajaki | Seed Round | 0 |
| 4/2020 | CyanoGuard AG | Seed Round | 0 |
| 6/2017 | 99RetailStreet | Seed Round | - |
| 11/2016 | Ava | Series A | 0 |
| 10/2016 | Rheon Medical | Venture Round | - |
| 10/2014 | Abionic | Series B | 0 |
| 1/2014 | Augurix | Venture Round | 0 |
| 8/2013 | Distalmotion | Series A | - |
| 4/2012 | Abionic | Series A | 0 |
| 7/2011 | Myopowers Medical Technologies | Series B | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
